Evaluation of Artificial Intelligence-Based Gleason Grading Algorithms “in the Wild”

2024-11-1

Claudin-18.2 immunohistochemical evaluation in gastric and gastroesophageal junction adenocarcinomas to direct targeted therapy: a practical approach

2024-11-1

Distinctive phenotypic and microenvironmental characteristics of neuroendocrine carcinoma and adenocarcinoma component in gastric mixed adenoneuroendocrine carcinoma

2024-10-1

Multicenter study on tumor budding in lung squamous cell carcinoma: comparison between biopsy and resection with interobserver variability assessment

2024-10-1

Malignant Sertoli-Leydig Cell Tumor With CTNNB1 Mutation Arising in a Cryptorchid Testis

2024-10-1

Enhancing Prostate Cancer Diagnosis: Artificial intelligence-Driven Virtual Biopsy for Optimal Magnetic Resonance Imaging-Targeted Biopsy Approach and Gleason Grading Strategy

2024-10-1

The Clinicopathological and Molecular Characteristics of Endocervical Gastric-Type Adenocarcinoma and the Use of Claudin18.2 as a Potential Therapeutic Target

2024-10-1

E-cadherin mutational landscape and outcomes in breast invasive lobular carcinoma

2024-10-1

RNA Sequencing May Call CEP170::RAD51B Fusion Because of Alignment Artifacts

2024-9-13

Abnormal p53 Immunohistochemical Patterns Are Associated with Regional Lymph Node Metastasis in Oral Cavity Squamous Cell Carcinoma at Time of Surgery

2024-9-1

Unraveling the molecular landscape of UTROSCT: Insights from a clinicopathological, morphological, immunohistochemical, and molecular analysis of 35 cases.

2024-9-1

Fluorescence Confocal Microscopy Can Accelerate Diagnosis of Cervical Lymphadenopathy

2024-9-1

p53-Abnormal Oral Epithelial Dysplasias Are Associated with High Risks of Progression and Local Recurrence - a Retrospective Study in a Longitudinal Cohort

2024-9-1

MYC Rearrangement Prediction from LYSA Whole Slide Images in Large B-cell Lymphoma: A Multi-centric Validation of Self-supervised Deep Learning Models

2024-9-1

Machine learning streamlines the morphometric characterization and multi-class segmentation of nuclei in different follicular thyroid lesions: everything in a NUTSHELL

2024-9-1

Comparison of Primary and Metastatic Fumarate Hydratase-Deficient Renal Cell Carcinomas Documents Morphologic Divergence and Potential Diagnostic Pitfall With Peritoneal Mesothelioma

2024-9-1

Pathologic Features of Malignancies Presenting as Asymmetry on Mammography

2024-9-1

Regulatory Aspects of AI-ML

2024-9-1

PLAG1-Rearranged Uterine Sarcomas: A Study of 11 Cases Showing a Wide Phenotypical Spectrum Not Limited to Myxoid Leiomyosarcoma-like Morphology

2024-9-1

Prognostic impact and genomic backgrounds of renal parenchymal infiltration or micronodular spread in non-metastatic clear cell renal cell carcinoma

2024-8-1

ARX, PDX1, ISL1 and CDX2 expression distinguishes five subgroups of PanNETs with correlations to histology, hormone expression and outcome

2024-8-1

The conflicting prognostic role of the stroma-ratio in breast cancer molecular subtypes

2024-8-1

ALK-rearranged renal cell carcinoma: a multi-institutional study of nine cases with expanding the morphologic and molecular genetic spectrum

2024-8-1

Superficial Neurocristic EWSR1::FLI1 Fusion Tumor: A Distinctive, Clinically Indolent, S100 Protein/SOX10-Positive Neoplasm

2024-8-1

An immunofluorescence-guided segmentation model in H&E images is enabled by tissue artifact correction by CycleGAN

2024-8-1

Histopathological, Molecular and Clinical Profiling of Lymphoepithelioma-Like Carcinoma of the Bladder (LELC-B)

2024-8-1

Spread Through Air Spaces (STAS): Inter-responder Agreement and Comparison between Pulmonary and General Pathologists

2024-8-1

Breast Cancer with HER2 IHC 2+ and Average HER2 Signals/Cell ≥ 6 and HER2/CEP17 Ratio < 2: A Multi-Institutional Cohort Analysis Emphasizing Outcome and Molecular Subtype

2024-8-1

Expression and Prognostic Significance of LAG-3, TIGIT, VISTA, and IDO1 in Endometrial Serous Carcinoma

2024-8-1

Acral fibrochondromyxoid tumor: a clinicopathologic and molecular genetic study of 37 cases

2024-8-1

Novel PAX3::MAML3 fusion identified in alveolar rhabdomyosarcoma, using DNA methylation profiling to expand the genetic spectrum of “fusion-positive” cases

2024-8-1

Squamoid Eccrine Ductal Carcinoma Displays UV-Mutations and Intermediate Gene Expression Relative to Squamous Cell Carcinoma, Microcystic Adnexal Carcinoma, and Porocarcinoma

2024-8-1

Targeted DNA sequencing in diagnosis of malignant phyllodes tumors with emphasis on tumors with keratin and p63 expression

2024-8-1

Methylation analysis to detect CIN3+ in hrHPV-positive self-samples from the population-based cervical cancer screening program

2024-8-1

Age-related clusters and favorable immune phenotypes in breast cancer of the young

2024-8-1

Chondroid Synoviocytic Neoplasm: A Clinicopathologic, Immunohistochemical and Molecular Genetic Study of a Distinctive Tumor of Synoviocytes

2024-8-1

Whole-Exome Sequencing of Vulvar Squamous Cell Carcinomas Reveals an Impaired Prognosis in Patients With TP53 Mutations and Concurrent CCND1 Gains

2024-7-31

Genomic Insights into High-Grade Infarct-Associated Bone Sarcomas

2024-7-20

Undifferentiated round cell sarcoma with CRTC1::SS18 fusion: Expanding clinicopathologic features of a rare translocation sarcoma with prominent desmoplastic stroma

2024-7-6

Novel AI Combining CNN and SVM to Predict Colorectal Cancer Prognosis and Mutational Signatures from HE Images

2024-7-1

Acute promyelocytic leukemia with torque teno mini virus (TTMV)::RARA fusion: an approach to screening and diagnosis

2024-7-1

Differential NEUROD1, ASCL1, and POU2F3 Expression Defines Molecular Subsets of Bladder Small Cell/Neuroendocrine Carcinoma with Prognostic Implications

2024-7-1

Beta-catenin Alterations in Post-Chemotherapy Yolk Sac Tumor, Postpubertal-Type with Enteroblastic Features

2024-7-1

Immunohistochemical profile of triple negative breast cancers: SOX10 and AR dual negative tumors have worse outcomes

2024-7-1

Proteomic Characterization of Undifferentiated Small Round Cell Sarcomas With EWSR1 and CIC::DUX4 Translocations Reveals Diverging Tumor Biology and Distinct Diagnostic Markers

2024-7-1

Myoepithelial Tumors of Bone with EWSR1::PBX3 Fusion: A Spectrum from Benign to Malignant

2024-7-1

Integration of Pathological Criteria and Immunohistochemical Evaluation for Invasive Lobular Carcinoma Diagnosis: Recommendations From the European Lobular Breast Cancer Consortium

2024-7-1

Wnt/beta-catenin activated non pilomatrical carcinoma of the skin: a case series

2024-7-1

Single-cell transcriptome analysis reveals two subtypes of tumor cells of sclerosing pneumocytoma with distinct molecular features and clinical implications

2024-7-1

Quantitative Measurement of HER2 Expression in Non-Small Cell Lung Cancer with a High Sensitivity Assay

2024-7-1